Degradation modules

C. Wiliam, N. Masson, Y.M. Tian, S.A. Mahmood, M.I. Wilson, R. Bicknell, K.U. Eckardt, P.H. Maxwell, P.J. Ratcliffe and C.W. Pugh, Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis. Proc. Natl. Acad Sci. USA. 99(16), 10423-10428 (2002). 

The Petri-Net degradation model developed in this work is a comprehensive model of the interactions between the previously identified failure modes in a PEMFC of standard construction. The standard construction is such that there is a PTFE based membrane, Carbon/Pt catalyst, steel BIP and carbon GDL. The individual degradation modules range from relatively simple relationships with 2 3 places and a low number of transitions, to larger modules with 8 places and 8 transitions. It contains 21 separate modules that interact to both dehver a voltage degradation value, and further interact with other failure modes. 

For each Petri-Net that has an output for which a reduction in performance is noted, a voltage drop count variable is used to store the total amount of degradation in performance due to the failure relationships. Therefore for each output place in a degradation module Petri-Net, a voltage drop figure is added to the overall voltage drop count. 

The results of the Petri-Net model using a SSC degradation module was tested using a polarisation curve model as in Figure 8. The model shows a good replication of the polarisation curve drop observed by Hong Kim, et al. (2010) in Figure 8. 

Modulation of second-messenger pathways is also an attractive target upon which to base novel antidepressants. Rolipram [61413-54-5] an antidepressant in the preregistration phase, enhances the effects of noradrenaline though selective inhibition of central phosphodiesterase, an enzyme which degrades cycHc adenosiae monophosphate (cAMP). Modulation of the phosphatidyl iaositol second-messenger system coupled to, for example, 5-HT,, 5-HT,3, or 5-HT2( receptors might also lead to novel antidepressants, as well as to alternatives to lithium for treatment of mania. Novel compounds such as inhibitors of A-adenosyl-methionine or central catechol-0-methyltransferase also warrant attention. 

Tf > 13% has been achieved for a three-stacked cell on a stainless steel substrate, and Tf > 10% for large area modules on a glass substrate that exhibit <15% degradation over several hundred hours of constant testing (7). 

ACE not only activates angiotensin but is also involved in the metabolism of other peptides, e.g., it is a major kinin-degrading enzyme. Therefore, ACE inhibitors also increase kinin concentrations. Furthermore, it has recently been shown that these drugs potentiate kinin effects by modulating a direct interaction between the ACE protein and the kinin B2 receptor, which is independent from the enzymatic activity of ACE. Kinin potentiation may be involved in the beneficial action of ACE inhibition since kinins are known to exert cardio- and renoprotective actions. 

The main consequences are twice. First, it results in contrast degradations as a function of the differential dispersion. This feature can be calibrated in order to correct this bias. The only limit concerns the degradation of the signal to noise ratio associated with the fringe modulation decay. The second drawback is an error on the phase closure acquisition. It results from the superposition of the phasor corresponding to the spectral channels. The wrapping and the nonlinearity of this process lead to a phase shift that is not compensated in the phase closure process. This effect depends on the three differential dispersions and on the spectral distribution. These effects have been demonstrated for the first time in the ISTROG experiment (Huss et al., 2001) at IRCOM as shown in Fig. 14. 

---